BUZZ-Tekmira Pharmaceuticals Corp: Completes patient enrollment
** U.S-listed shares of Canadian drugmaker up 22 pct at $17, Toronto-listed shares up 15 pct at C$18.58
** Company says completes patient enrollment in early-stage study of its cancer drug TKM-PLK1
** Tekmira says it expects final data in mid-2015
** More than 1 mln shares changed hands on Nasdaq by 10.24 am ET; more than 3 times the 10-day moving average; About 148,000 shares traded in Toronto, about average
** Up to Tuesday's close, stock had risen 74 pct this year, largely due to excitement over its potential Ebola drug
© Thomson Reuters 2017 All rights reserved.